Reinhard Hilgers
Goettingen, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Prevalence of Back Pain among German Ophthalmologists.
Journal: Ophthalmic research
Published: March 05, 2021
ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis.
Journal: Frontiers in neurology
Published: January 24, 2019
Efficacy and safety of a fixed bimonthly ranibizumab treatment regimen in eyes with neovascular age-related macular degeneration: results from the RABIMO trial.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: October 19, 2016
Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial.
Journal: The Lancet. Oncology
Published: May 16, 2014
Comparison of Two Clinical Protocols for Total Intravenous Anesthesia (TIVA) for Breast Surgery Using Propofol Combined With Either Sufentanil or Alfentanil.
Journal: Anesthesiology and pain medicine
Published: April 05, 2014
Do different vaginal tapes need different suburethral incisions? The one-half rule.
Journal: Neurourology and urodynamics
Published: January 22, 2014
Challenges for academic investigator-initiated pediatric trials for rare diseases.
Journal: Clinical therapeutics
Published: November 25, 2013
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Journal: Annals of neurology
Published: August 29, 2012
Reduction in treatment times through formalized data feedback: results from a prospective multicenter study of ST-segment elevation myocardial infarction.
Journal: JACC. Cardiovascular interventions
Published: March 09, 2012
Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients.
Journal: ISRN pediatrics
Published: March 04, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026